British Patient Capital
Chloe Hall, CFA has a diverse work experience spanning various roles and companies. 🤖Chloe is currently working at British Patient Capital as an Investment Manager. In addition, they sserveas a Board Observer at companies including Quantum Motion, Ultraleap, and CloudNC. Chloe Hall also worked as a Fellow at the Newton Venture Program, a joint venture between London Business School and LocalGlobe VC. Prior to that, they held Board Observer positions at Healthera and B-Secur. 🤖Chloe also had a Secondment role at ADV. Earlier in their career, Chloe Hall worked at Legal & General as an Investment Associate in the Health and Care sector and as an Investment Analyst. 🤖Chloe started their career as an Associate at Renevo Capital Limited.
Chloe Hall, CFA, obtained their MChem degree in Chemistry from the University of Oxford in 2016. 🤖Chloe then pursued further education and completed the Chartered Financial Analyst (CFA) program from the CFA Institute between 2018 and 2021, obtaining the CFA designation in August 2021.
In addition to their formal education, Chloe has also acquired several certifications. In December 2018, they obtained the CFA Level 1 certification from the CFA Institute. 🤖Chloe followed up with the CFA Level 2 certification in August 2019. Furthermore, Chloe has completed the "Brad Feld on Validating Your Startup Idea" and "Negotiation Foundations" certifications in December 2020, both from LinkedIn.
In 2022, Chloe attended the London Business School as a Newton VC Fellow, focusing on Venture Capital.
This person is not in any offices
British Patient Capital
British Patient Capital invests in a diversified portfolio of best-in-class venture and growth capital funds and start ups, capturing value through financing the growth of innovative companies. We invest on a commercial basis to deliver competitive returns and manage risk.As well as providing our own funding we work to encourage more investors tomake allocations to this asset class by demonstrating that a long-term patient capital investment strategy can produce commercially attractive returns.Once we’ve established a strong record, and have proved the value of the asset class, we intend to privatise British Patient Capital at an appropriate time in the future.